Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Dec;6(Suppl 2):S134.
doi: 10.21037/atm.2018.12.52.

Empagliflozin as an adjunctive therapy for type 1 diabetes

Richard J MacIsaac  1   2 , Melissa H Lee  1   2 , Sybil A McAuley  1   2 , Glenn M Ward  1   2 , David N O'Neal  1   2
Affiliations
Editorial

Empagliflozin as an adjunctive therapy for type 1 diabetes

Richard J MacIsaac et al. Ann Transl Med. 2018 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Professor Richard MacIsaac has received honoraria and travel support for lectures from Eli lily, Novo Nordisk, Sanofi Aventis, Astra Zeneca, Merck Sharp & Dohme and Norvartis. He has received research grants from Novo Nordisk and Sevier. Dr. Sybil A. McAuley has received speaker honoraria for lectures from Novo Nordisk and Eli Lilly; travel support from Novo Nordisk; and research support from Medtronic. David O’Neal: has received travel support from Novo-Nordisk; honoraria for lectures from Novo Nordisk, Sanofi Aventis, Merck Sharp & Dohme, Medtronic and Dexcom; He has received research grants and research support from Novo Nordisk, Medtronic, Roche, Sanofi-Aventis; Abbott, and Eli-Lily. He has been on advisory boards for Novo-Nordisk, Medtronic, Abbott and Sanofi-Aventis.

Comment on

References

    1. Nathan DM, Bayless M, Cleary P, et al. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes 2013;62:3976-86. 10.2337/db13-1093 - DOI - PMC - PubMed
    1. McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med 2015;32:1036-50. 10.1111/dme.12676 - DOI - PubMed
    1. Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 2015;38:971-8. 10.2337/dc15-0078 - DOI - PubMed
    1. Conway B, Miller RG, Costacou T, et al. Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med 2010;27:398-404. 10.1111/j.1464-5491.2010.02956.x - DOI - PMC - PubMed
    1. Pickup JC. Is insulin pump therapy effective in Type 1 diabetes? Diabet Med. 2018. [Epub ahead of print]. 10.1111/dme.13793 - DOI - PubMed